Compound ID | 3286
Synonym(s): WX-081 | WX 081 | WX081 | fudapirine
Class: Diarylquinoline
Details of activity: | Active against Mycobacterium tuberculosis |
Description: | Synthetic compound (diarylquinoline); analogue of bedaquiline; shows favourable pharmacokinetics and reduced toxicity than bedaquiline |
Institute where first reported: | Shanghai Jiatan Pharmatech Co., Ltd |
Year first mentioned: | 2022 |
Highest developmental phase: | Phase 3 (NCT05824871) |
Development status: | Active (as of 2024) |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/156777270 |
Guide to Pharmacology: | fudapirine |
Citation: | https://journals.asm.org/doi/10.1128/spectrum.02477-21 |